Autopsy report · NCT02162225

Study of Beet Juice for Patients With Sickle Cell Anemia

“Enrollment was very slow. Hope to reopen as multi-site study”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Wake Forest University Health Sciences

Sponsor type

University, hospital or other

Conditions

Sickle Cell Anemia

Interventions

beet juice (Unbeetable)

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Ruxolitinib for Early Lung Dysfunction After Hematopoietic Stem Cell Transplant
  “Study closed due to slow enrollment.” (76% match in meaning)
• Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer
  “The study was halted because enrollment was too slow” (74% match in meaning)
• A Study of CPX-351 (Vyxeos™) With Quizartinib for the Treatment of FLT3-ITD Mutation-Positive Acute Myeloid Leukemia
  “Closed due to slow enrollment” (73% match in meaning)
• Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer
  “The study was closed to enrollment due to slow accrual.” (72% match in meaning)
• LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
  “Study was discontinued due to slow enrollment” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.